Peptide Synthesis Market: Impact Analysis of Drivers, Restraints, Opportunities, and Challenges

The peptide synthesis market is projected to reach USD 426.4 million by 2023 from USD 310.5 million in 2018, at a CAGR of 6.5% during the forecast period. Factors such as the growing use of peptides in pharmaceutical drugs, increase in research activities and availability of funding for R&D, and the development of advanced peptide synthesizers are expected to drive the growth of the market. However, the lack of a unified set of regulations for therapeutic peptides is expected to restrain the growth of this market during the forecast period.

Years considered for this report

# 2017 – Base Year

# 2018 – Estimated Year

# 2023 – Projected Year

Download the PDF Brochure for More Details@ http://bit.ly/2Mo8CfU


Objectives of the Study

• To define, describe, and forecast the peptide synthesis market on the basis of product, technology, end user, and region.
  
• To provide detailed information about factors influencing market growth (drivers, restraints, opportunities, and industry-specific challenges).
  
• To strategically analyze micromarkets with respect to the individual growth trends, prospects, and contributions to the overall market.
  
• To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players.
  
• To forecast the size of the market segments in North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.
  
• To profile key players and comprehensively analyze their market shares and core competencies in the global peptide synthesis market.
  
• To track and analyze competitive developments such as partnerships, agreements, & collaborations; mergers & acquisitions; product developments; and geographical expansions in the global peptide synthesis market

Restraint:
Lack of A Unified Set of Regulations for Therapeutic Peptides

Opportunity:
Emerging Markets in the Asia Pacific Region

Challenge:
Issues Associated With the Route of Administration of Peptide Drugs

Research Methodology:

Top-down and bottom-up approaches were used to validate the size of the global peptide synthesis market and estimate the size of various other dependent submarkets. Major players in the market were identified through secondary sources secondary sources; directories; databases such as Hoovers, Bloomberg Businessweek, Factiva, and OneSource, journals and their market revenues were determined through primary and secondary research. Secondary research included the study of the annual and financial reports of top market players, whereas primary research included extensive interviews with the key opinion leaders such as CEOs, directors, and marketing executives. 

The percentage splits, shares, and breakdowns of the product markets were determined using secondary sources and verified through primary sources. All possible parameters that affect the market covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. This data is consolidated and added with detailed inputs and analysis from MarketsandMarkets and presented in this report.

Read the Detailed Article@ https://www.marketsandmarkets.com/Market-Reports/peptide-synthesis-market-158927365.html

The prominent players in the peptide synthesis market are GenScript Biotech Corporation (China), AAPPTec (US), Bachem (Switzerland), AnaSpec (US), Biotage (Sweden), CEM Corporation (US), Gyros Protein Technologies (Sweden), Advanced ChemTech (US), Merck KGaA (Germany) and New England Peptide, Inc (US). Product launches and agreements, partnerships and collaborations were the major strategies adopted by these payers to maintain their positions in the peptide synthesis market.

Target Audience:

• Biotechnology & pharmaceutical companies
• Market research and consulting firms
• Venture capitalists and investors
• Research & development companies
• Contract research organizations (CROs)
• Academic research institutes
• Government institutes